15 May 2021: Database Analysis
H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro
Min Luo 1ABCE , Yao Xiong 2BCE , Yan Lin 1CD , Rong Liang 1CD , Yongqiang Li 1D , Lianying Ge 3ADE*DOI: 10.12659/MSM.930215
Med Sci Monit 2021; 27:e930215
Table 2 The expression level of HHLA2 mRNA in HepG2 cells.
| Group | HHLA2 mRNA expression |
|---|---|
| HepG2-NC | 1.003±0.092 |
| HepG2+shRNA 1 | 0.300±0.013* |
| HepG2+shRNA 2 | 0.997±0.071 |
| HepG2+shRNA 3 | 0.992±0.028 |
| * =0.006. | |